FDA Issues Bread Recall Update After Glass Discovered in Crusts
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The U.S. Food and Drug Administration (FDA) has ended a voluntary recall of 800 items after glass fragments were discovered in the crusts of several breads.
Maryland-based Upper Crust Bakery LP initiated the recall regarding products distributed to six states: Pennsylvania, California, Connecticut, Maryland, Delaware, and Ohio.
Upper Crust Bakery LP, operating out of Glenn Dale, voluntarily recalled three varieties of bread—Ancient Grains Hoagie Roll, Multigrain Sourdough, and Whole Grain Multigrain—after a team member discovered a glass fragment on a piece of seeded bread.
The recall initially began on April 12, 2025, and the FDA classified it as Class II on April 25, the second-highest of three risk levels, which indicates the potential for temporary or reversible health consequences.
The FDA terminated the recall on July 15.
Stock image of sourdough bread slices.
Stock image of sourdough bread slices.
Getty Images
Why it Matters
The FDA warned that consuming glass fragments could cause injuries ranging from cuts in the mouth and throat to intestinal perforation—a risk prompting significant public attention.
What To Know
According to FDA records, the recall covered three products:
Ancient Grains Hoagie Roll , 4 oz, Lot #90, 89 cases, carton code CP45, distributed frozen
, 4 oz, Lot #90, 89 cases, carton code CP45, distributed frozen Multigrain Sourdough , 18 oz, Lot #90, 699 cases, carton code CP12, distributed frozen
, 18 oz, Lot #90, 699 cases, carton code CP12, distributed frozen Whole Grain Multigrain, 20 oz, Lot #92, 30 cases, carton code CP12, distributed frozen
The bakery, operating as Crest Hill Bakery, notified the FDA after an employee discovered a glass fragment during a routine inspection. Further investigation traced the source of the glass to sunflower seeds provided by supplier Magic Flame.
Upper Crust Bakery LP stated that it immediately ceased using ingredients from the implicated supplier and removed all affected products from circulation.
"We have ceased the use of sunflower seeds from the manufacturer associated with the glass fragments, Magic Flame," the company said in a statement announcing the recall.
For consumers, the FDA and Upper Crust Bakery LP advised that bread with affected lot numbers should not be consumed but instead discarded or returned to the point of purchase for a refund. Health experts emphasized contacting a health care provider if glass ingestion is suspected due to the risk of gastrointestinal injury.
Who People Are Saying
Upper Crust Bakery LP, in a statement announcing the recall: "The recall was initiated after a vigilant team member discovered a small glass fragment on top of a piece of seeded bread."
"We remain steadfast in our commitment to upholding the highest standards of quality and safety in all our products," the company added.
The FDA warned at the time: "The agency warns that consuming glass fragments can result in significant injuries such as damage to teeth, lacerations of the mouth and throat, or perforation of the intestine."
What Happens Next
With the recall terminated as of July 15, 2025, Upper Crust Bakery LP stated that it has stopped sourcing sunflower seeds from the implicated supplier and has amended its food safety checks.
For further updates on food recalls and safety guidance, visit the FDA's official recall search portal.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
2 hours ago
- Newsweek
Tuna Salad Products Recall Map Shows States With New Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Albertsons, Randalls and Tom Thumb stores in four states are recalling certain items containing tuna salad supplied by Reser's Fine Foods due to fears of potential Listeria contamination. Newsweek reached out to Albertsons via email Monday night for comment. Why It Matters Listeria monocytogenes is a bacterium capable of causing serious and sometimes fatal infections, especially in pregnant women, older adults, infants, and people with weakened immune systems. Pregnant women are about 10 times more likely to be infected, and those from Hispanic backgrounds face an even higher risk. For these individuals, exposure can result in miscarriage, stillbirth, hospitalization, or death. The FDA describes listeriosis as the third leading cause of death from food poisoning in the United States. Numerous recalls have been initiated in 2025 due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. What To Know The FDA says in their alert, that there have been no reports of injuries or illnesses related to the recall. "Anyone concerned about an injury or illness should contact a healthcare provider," the FDA says. The alert also lists in a chart the product details for the impacted tuna salad items with corresponding UPC numbers, sizes and sell through dates. Below is a map of the states impacted by the recall, which includes Arkansas, Texas, Louisiana, and Oklahoma. What People Are Saying The FDA in part in the alert: "The FDA recommends in these cases that anyone who purchased or received any recalled products to use extra vigilance in cleaning and sanitizing any surfaces and containers that may have come in contact with these products to reduce the risk of cross-contamination. Listeria monocytogenes can survive in refrigerated temperatures and can easily spread to other foods and surfaces." What Happens Next People who have purchased the recalled product are urged to throw the product away or return it to the original place of purchase for a full refund, the FDA says. Those with additional questions may contact Albertsons Companies' Customer Service Center on weekday at 1-877-723-3929 from 5 a.m. to 9 p.m. PT. Consumers can also find updates and comprehensive advice on minimizing listeria risks at the FDA's food safety page. Those at high risk should consider additional preventative measures, including using refrigerator thermometers, consuming ready-to-eat foods promptly, and avoiding high-risk foods such as unpasteurized cheeses and smoked seafood unless heated.
USA Today
3 hours ago
- USA Today
Hunter Biden blames dad's disastrous Trump debate on Ambien. What is it?
Could Ambien be the reason behind former President Joe Biden's widely criticized debate performance against Donald Trump last year? Hunter Biden thinks so. During a more than three-hour interview on the YouTube show Channel 5 with Andrew Callaghan that aired on July 21, Hunter Biden said his dad was experiencing effects from the prescription sleep aid while debating now-president Trump. "I know exactly what happened in that debate," Hunter Biden said in a three hour-plus interview on the YouTube show Channel 5 with Andrew Callaghan that aired July 21. "He flew around the world ‒ basically the mileage that he could have flown around the world three times. He's 81 years old. He's tired as s--t. They give him Ambien to be able to sleep. He gets up on the stage, and he looks like he's a deer in the headlights, and it feeds into every f---ing story that anybody wants to tell." Biden isn't the only public figure to blame regrettable behavior on Ambien. Years ago, Sen. Robert F. Kennedy's daughter Kerry Kennedy blamed Ambien for a drugged-driving incident, for which she was acquitted in 2014. In 2018, comedian Roseanne Barr said she was "Ambien tweeting" when a racist tweet of hers about Obama White House aide Valerie Jarrett led to the cancelation of her ABC sitcom. But what exactly is Ambien − and how does it affect the human body? Here's what to know about the prescription sleep aide. What is Ambien? Ambien, also known by its generic name, zolpidem, is a prescription medication used to treat insomnia by helping individuals fall asleep quicker and stay asleep. The Food and Drug Administration has expressed concern over how Ambien can impair activities, such as driving, especially into the morning hours. "Patients with high levels of zolpidem can be impaired even if they feel fully awake," the FDA wrote in a fact sheet about the medication. A year ago: The Biden-Trump debate rematch that changed the election Joe Biden, now 82, and his former White House aides have previously blamed the president's busy schedule for his poor debate performance on June 27, 2024, but have not publicly mentioned Ambien. A representative for the former president did not respond to a request from USA TODAY about Hunter Biden's remarks about the sleeping drug. What are the side effects of Ambien? Ambien's side effects include nausea, vomiting, muscle cramps and diarrhea. The medication can also cause abnormal thinking and changes in behavior: "Some of these changes may be characterized by decreased inhibition ... similar to effects produced by alcohol," the FDA-approved labeling says. Confusion and aggressiveness are also listed side effects. "Visual and auditory hallucinations have been reported as well as behavioral changes such as bizarre behavior, agitation and depersonalization," the label adds. Previously: Hunter Biden says Joe Biden was taking Ambien before disastrous debate against Trump The label also warns against a possible worsening of depression or suicidal thinking. Impairments to alertness, motor coordination and vision have also been reported. Complex sleep behaviors, during which a person engaged in activities while not fully away, such as sleepwalking, sleep-driving and sleep-cooking, have also been associated with Ambien, the American Addiction Centers reports. Additionally, the drug has been linked to amnesia. What have others said about Ambien? After Barr's comment about "Ambien tweeting," Sanofi, a pharmaceutical company that makes Ambien, tweeted in response: "While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication." Ambien was also one of the drugs found in Tiger Woods' system after police found him asleep in his car in the middle of a highway. Other Ambien users have reported a variety of side effects, including sleepwalking, binge eating and even driving at night without realizing or remembering the incidents. Ambien maker to Roseanne: Racism is not a side effect of our drug Janet Makinen, one of the lead plaintiffs in a 2006 class-action lawsuit against Ambien maker Sanofi-Aventis' U.S. division, alleged she 'ate hundreds of calories of food, including raw eggs, uncooked yellow rice, cans of vegetables, loaves of bread, bags of chips and bags of candy' while on the medication, according to an amended complaint in the lawsuit filed in the Southern District of New York. The lawsuit also alleged that fellow plaintiff Christina Brothers, a financial analyst, remembers taking Ambien one night in May 2005 and waking up 'on the concrete floor of a jail cell.' The parties agreed to a stipulated dismissal in 2007 because differences in factual issues and the women's injuries made it impossible for the case to be certified as a class-action lawsuit on behalf of other Ambien users. Contributing: Joey Garrison and Ashley May
Yahoo
3 hours ago
- Yahoo
FDA panel promotes misinformation about antidepressants during pregnancy, psychiatrists say
A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to misinformation or facts taken out of context, according to several psychiatrists who tuned in to the meeting. The panel had promised to feature diverse viewpoints about antidepressants and pregnancy. But nearly all of the 10 panelists bucked medical consensus on the drugs' safety and emphasized what they said were risks of taking the drugs while pregnant — such as causing autism, miscarriages or birth defects. In some cases, they claimed that antidepressants don't work at all and that depression goes away on its own. Three of the 10 panelists were from outside the United States. Another runs a clinic to help people taper off of psychiatric drugs. 'They were really rousing concerns about safety that are not evidence-based or established and not at all balanced with concerns about the risks of untreated depression,' said Dr. Joseph Goldberg, a clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City. Dr. Jennifer Payne, director of the Reproductive Psychiatry Research Program at the University of Virginia, said, 'I'm disappointed that the FDA brought people in from outside of the United States when there's so many experts here in the United States who truly know this [medical] literature inside and out.' A spokesperson for the FDA said in a statement that the claim that the panel was one-sided was 'insulting to the independent scientists, clinicians, and researchers who dedicate their expertise to these panels.' The spokesperson added that FDA Commissioner Martin Makary 'has an interest in ensuring policies reflect the latest gold standard science and protect public health.' Health and Human Services Secretary Robert F. Kennedy Jr. has called for a probe into the risks of antidepressants. His 'Make America Healthy Again' report in May claimed there were 'potentially major long-term repercussions' associated with use of the drugs in childhood. The panel discussion focused on a class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, which includes Lexapro, Prozac and Zoloft. The medications increase levels of serotonin, a chemical messenger in the brain that can improve mood. Psychiatrists often advise women who are taking SSRIs to continue doing so during pregnancy, since the risks of untreated depression tend to outweigh the potential risks of the medication to mother and child. However, the decision is a personal one. For ethical reasons, there are no randomized-control trials of SSRIs in pregnant women, meaning data on potential risks mostly comes from observational studies and drug registries. Some babies born to mothers taking SSRIs may develop symptoms such as jitteriness, irritability or difficulty eating or sleeping that resolve quickly — what's known as 'neonatal adaptation syndrome.' The symptoms may be caused by medication in the babies' systems or withdrawal from it. Certain studies have also found a slightly elevated risk of miscarriage associated with antidepressant use in pregnancy, though others have found no association. However, there's no convincing evidence to suggest that SSRIs are linked to autism or birth defects. 'Well-controlled studies continue to not find an association,' Payne said. Women with histories of depression are also at an increased risk of symptoms' recurring during pregnancy, and depression can come with its own risks — including thoughts of self-harm or low birth weight. 'The best thing a pregnant individual could do for herself and her baby is to get the treatment that they need,' said Dr. Nancy Byatt, a perinatal psychiatrist at UMass Chan Medical School, who wasn't part of the panel. In addition to raising concerns about side effects, several panelists questioned the efficacy of antidepressants or suggested that data favoring the use of SSRIs was manipulated by the pharmaceutical industry. 'It's been said that SSRIs help people who are severely depressed. They don't,' said David Healy, an FDA panelist and fellow at the Royal College of Psychiatrists in the United Kingdom. Goldberg and other psychiatrists said that's simply untrue. 'You can say the moon landing was faked. Conspiracy theories abound in our world. But there is not a doubt about whether SSRIs work,' said Goldberg, a past president of the American Society of Clinical Psychopharmacology who has previously consulted for pharmaceutical companies. He said he was invited to join the FDA panel but declined because the language of the invitation suggested it wouldn't be a fair discussion. Healy, the panelist, also claimed that some people 'recover spontaneously' from depression. Another panelist, psychologist Roger McFillin — who hosts a podcast that challenges conventional mental health advice — suggested that depression wasn't an illness but rather a product of 'women just naturally experiencing their emotions more intensely.' He added, without evidence, that many women feel coerced into taking antidepressants. Psychiatrists who weren't part of the discussion broadly decried those characterizations. 'I have never, ever, ever, ever heard of a third party pushing a prescription in pregnancy,' Goldberg said. However, he said he is aware of some obstetrician-gynecologists who aren't as familiar with SSRIs who have wrongly told pregnant patients to stop taking the medications. The American College of Obstetricians and Gynecologists said in a statement Monday that SSRIs can be lifesaving for some pregnant people. 'Today's FDA panel on SSRIs and pregnancy was alarmingly unbalanced and did not adequately acknowledge the harms of untreated perinatal mood disorders in pregnancy,' it said. 'On a panel of 10 experts, only one spoke to the importance of SSRIs in pregnancy as a critical tool, among others, in preventing the potentially devastating effects of anxiety and depression when left untreated during pregnancy.' One panelist, Dr. Kay Roussos-Ross, a psychiatrist and an OB-GYN at the University of Florida College of Medicine, was the most vocal advocate for using SSRIs, often pushing back against others' assessments of the risks. Psychiatrists who weren't on the panel praised her science-backed commentary. 'All of us can find a study that agrees with exactly what we think,' Roussos-Ross told the panel. 'But we need to look at the data very objectively.' Several psychiatrists who weren't on the panel said they worry that the discussion could lead to regulatory action that makes it harder to access SSRIs. For example, one panelist, Dr. Adam Urato, chief of maternal-fetal medicine at MetroWest Medical Center in Framingham, Massachusetts, called for stronger warnings on SSRI labels. 'I am just very nervous that some of the discourse around the risks of antidepressants could lead to even more barriers for people seeking care,' said Dr. Lindsay Lebin, an assistant professor of psychiatry at the University of Colorado Anschutz Medical Campus, who wasn't part of the FDA discussion. This article was originally published on Solve the daily Crossword
